Showing results (611-620 of 831) with videos related to
Sort By:
Pageof 84
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastomaStephan A Grupp, Eline Luning Prak, Jean Boyer, et al.Blood|November 16, 2004
Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)David T Teachey, Catherine S Manno, Kelly M Axsom, et al.Biomed Research International|April 18, 2015
Biomaterial hypersensitivity: is it real? Supportive evidence and approach considerations for metal allergic patients following total knee arthroplastyAndrew J Mitchelson, Craig J Wilson, William M Mihalko, et al.Kidney & Blood Pressure Research|January 1, 1996
The German Glomerulonephritis Therapy Study: 10 years of controlled randomized trials for the treatment of idiopathic glomerulonephritisT Risler, N Braun, D Bach, et al.JAMA Network Open|December 21, 2019
Effect of a Motivational Interviewing-Based Intervention on Initiation of Mental Health Treatment and Mental Health After an Emergency Department Visit Among Suicidal Adolescents: A Randomized Clinical TrialJacqueline Grupp-Phelan, Jack Stevens, Stephanie Boyd, et al.Bone Marrow Transplantation|March 2, 2010
Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031G D E Cuvelier, A Kariminia, H Fujii, et al.Blood|June 17, 2009
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313Michael A Pulsipher, Kenneth M Boucher, Donna Wall, et al.European Journal of Cancer (Oxford, England : 1990)|January 2, 2014
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletionsKatharina Grupp, Julia Wilking, Kristina Prien, et al.Journal of Molecular and Cellular Cardiology|May 10, 2001
The enhanced contractility of the phospholamban-deficient mouse heart persists with agingJ P Slack, I L Grupp, R Dash, et al.Pageof 84